Objective-An excessive release and impaired degradation of neutrophil extracellular traps (NETs) leads to the continuous exposure of NETs to the endothelium in a variety of hematologic and autoimmune disorders, including lupus nephritis. This study aims to unravel the mechanisms through which NETs jeopardize vascular integrity. Approach and Results-Microvascular and macrovascular endothelial cells were exposed to NETs, and subsequent effects on endothelial integrity and function were determined in vitro and in vivo. We found that endothelial cells have a limited capacity to internalize NETs via the receptor for advanced glycation endproducts. An overflow of the phagocytic capacity of endothelial cells for NETs resulted in the persistent extracellular presence of NETs, which rapidly altered endothelial cellcell contacts and induced vascular leakage and transendothelial albumin passage through elastase-mediated proteolysis of the intercellular junction protein VE-cadherin. Furthermore, NET-associated elastase promoted the nuclear translocation of junctional β-catenin and induced endothelial-to-mesenchymal transition in cultured endothelial cells. In vivo, NETs could be identified in kidney samples of diseased MRL/lpr mice and patients with lupus nephritis, in whom the glomerular presence of NETs correlated with the severity of proteinuria and with glomerular endothelial-to-mesenchymal transition.
N eutrophil extracellular traps (NETs) are fibrillary networks of DNA, histones, and antimicrobial peptides that are released from neutrophils during a highly complex cell death signaling pathway termed NETosis. 1 NETosis was first described in 2004 as a novel defense mechanism of the innate immune system against intruding pathogens, but during the last years, it has become increasingly clear that NETs can also exert deleterious effects on the host. 2 An imbalance between the release and degradation of NETs has been linked to a variety of hematologic disorders, such as transfusionrelated acute lung injury, 3, 4 sickle cell disease, 5 thrombosis, 6 and myeloproliferative neoplasms. 6 Aberrant NETosis has also been associated with autoimmune conditions, such as antineutrophil cytoplasmic antibody-associated vasculitis 7 and systemic lupus erythematosus, 8, 9 in which NET-associated antigens may become targets of autoantibodies. In systemic lupus erythematosus, the failure to dismantle NETs has been specifically linked to the development of lupus nephritis (LN), but the underlying mechanisms for this association are as yet still unresolved. 10 NETs contain an arsenal of cytotoxic proteases, including cathepsin G, proteinase 3, neutrophil serine protease 4, matrix metalloproteinase 9 (MMP9), and neutrophil elastase. 11 In addition, NETs are rich in cytotoxic (modified) histones. 12 Although NET-associated histones and proteases exert a pivotal role in the elimination of pathogens, they may also injure surrounding tissues and bystander cells. The endothelium may be particularly at risk for NET-mediated damage because endothelial cells are continuously exposed to NETs in NET-driven disorders. [13] [14] [15] Especially the endothelial cells that line the renal glomeruli are thought to be heavily subjected to NETs because circulatory NETs may deposit here in locally high amounts during blood filtration. 16, 17 To date, the effects of NETs on endothelial cells still remain poorly characterized. In the present study, we investigated the effects of NETs on macrovascular human umbilical vein endothelial cells (HUVECs) and microvascular glomerular endothelial cells (ciGEnCs) both in vitro and in vivo. We observed that NETs alter endothelial cell-cell contacts through the proteolysis of the intercellular junction protein VE-cadherin by NET-associated elastase, thereby facilitating vascular leakage and the transendothelial passage of albumin. In addition, cultured endothelial cells underwent endothelialto-mesenchymal transition (EndMT) in response to NETs, which was also dependent on the proteolytic activity of elastase. The relevance of these in vitro findings was further evaluated in vivo, where NET depositions could be demonstrated in renal biopsies of diseased MRL/lpr mice, as well as human LN subjects, in whom the glomerular presence of NETs correlated with the degree of proteinuria and with glomerular EndMT. Collectively, our data reveal that NETs play a crucial role in the induction of vascular leakage and EndMT.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Endothelial Cells Internalize NETs in a Receptor for Advanced Glycation EndproductDependent and Clathrin-Dependent Manner
Previously, macrophages were shown to play an important role in clearance of NETs. 18 Endothelial cells are also capable to internalize a wide variety of cellular material, that is, senescent neutrophils, 19 apoptotic debris, 20 and red blood cells. 21 Because endothelial cells are continuously exposed to NETs in NET-driven disorders, [13] [14] [15] [16] [17] we first evaluated whether endothelial cells have the capacity to internalize NETs. Such an endothelial phagocytic clearance may be crucial to avoid uncontrolled NET-mediated endothelial damage. To assess endothelial uptake of NETs, microvascular ciGEnCs or macrovascular HUVECs were incubated with NETs and the culture medium was analyzed for NETs at various time points with the cell-impermeable, DNA-binding dye Sytox Orange. A rapid (<15 minutes) and time-dependent uptake of NETs by both ciGEnCs and HUVECs was observed ( Figure 1A) , which was more pronounced in ciGEnCs. To further validate internalization of NETs by endothelial cells, ciGEnCs were stained for neutrophil elastase, the most abundant protease within NETs. 11 Indeed, NET-treated ciGEnCs showed an intracellular particulate staining for elastase, which was absent in control ciGEnCs ( Figure IA in the online-only Data Supplement). Moreover, elastase colocalized with clathrin ( Figure IB in the online-only Data Supplement), indicating a receptor-mediated pathway of endocytosis that leads to the formation of clathrin-coated NET-containing endosomes. Besides elastase, NET-derived histones were found in clathrincoated endosomes after exposure of ciGECs or HUVECs to NETs ( Figure 1B , middle panel; Figure IC in the online-only Data Supplement). Because NETs are primarily composed of DNA, we reasoned that the receptor for advanced glycation endproducts (RAGE), a transmembrane receptor of the immunoglobulin super family that was previously shown to promote the uptake of extracellular DNA into endosomes, 22 could be the receptor responsible for the internalization of NETs into clathrin-coated endosomes. Indeed, the full digestion of NETderived DNA with DNase I prevented the uptake of NETderived histones into clathrin-coated endosomes as observed by immunofluorescence imaging ( Figure 1B , bottom panel). Furthermore, in the presence of FPS-ZM1, an antagonist of RAGE, both HUVECs and ciGEnCs were unable to internalize NETs ( Figure 1C ). The uptake of NETs by ciGEnCs or HUVECs did also not occur at 4°C, indicating that the uptake of NETs is an active process ( Figure 1C ). In summary, NETs are rapidly internalized by endothelial cells during an active process involving both RAGE and clathrin.
NET-Associated Elastase Promotes Transendothelial Albumin Passage
Despite a rapid uptake of NETs, the phagocytic capacity of endothelial cells for NETs seemed to be limited. Addition of larger amounts of NETs (≥250-ng NET-derived DNA) to endothelial cells resulted in the saturation of their phagocytic capacity thereby causing a persistent extracellular presence of NETs ( Figure 2A ). We used HUVECs as a model to study the extracellular effects of NETs on endothelium because the phagocytic capacity of HUVECs for NETs was significantly lower than that of ciGEnCs ( Figure 1A ). At high NET concentrations (2-µg DNA/mL), a rapid loss of endothelial cell-cell contacts and an impaired endothelial monolayer integrity could be observed ( Figure IIA in the online-only Data Supplement), which was not the result of NET-mediated endothelial cell death as measured by Annexin V staining ( Figure IIB in the online-only Data Supplement). To further characterize endothelial integrity, the expression of the intercellular (junctional) proteins CD31 and VE-cadherin was analyzed, which revealed that both CD31 and VE-cadherin expression was significantly decreased on NET-treated HUVECs ( Figure 2B and 2C). The loss of VE-cadherin expression furthermore coincided with the gradual development of a spindle-shaped, mesenchymal-like phenotype, which was most prominent after 24 hours ( Figure 2D albumin passage assay was performed, which revealed that the transendothelial passage of albumin was significantly increased in NET-treated HUVECs compared with control HUVECs ( Figure 2E ). Because VE-cadherin and CD31 are known substrates of elastase 23 and MMP9, 24 respectively, we assessed whether we could prevent the loss of these junctional proteins and subsequent transendothelial albumin passage by inhibiting the activity of NET-associated elastase and MMP9. Pre-treatment of NETs with sivelestat, a selective inhibitor of elastase, 25 abolished the NET-induced loss of VE-cadherin expression ( Figure 2F and 2G) and reduced transendothelial albumin passage ( Figure 2E ). The inhibition of MMP9 with anti-MMP9 antibodies could limit CD31 loss ( Figure IID in the online-only Data Supplement), but this did not alter endothelial monolayer integrity (data not shown). Taken together, the extracellular presence of NET-associated elastase promotes the proteolysis of VE-cadherin, which disturbs endothelial monolayer integrity and promotes transendothelial passage of albumin.
NET-Associated Elastase Promotes EndMT
β-catenin, a dual function protein involved in cell-cell adhesion and gene transcription, is associated with the cytoplasmic tail of VE-cadherin in endothelial cells. 26 It was previously shown that the loss of cadherin-mediated cell-cell adhesions can promote junctional β-catenin release and induce β-catenin signaling. 27, 28 Congruent with these reports, NETs promoted the nuclear translocation of junctional β-catenin ( Figure IIIA and IIIB in the online-only Data Supplement), which was most prominent after 24 hours. The translocated β-catenin most likely is transcriptionally active within the nucleus as demonstrated by immunofluorescence stainings with an antibody specific for transcriptionally active β-catenin, that is, recognizing dephosphorylated Ser37 and Thr41 epitopes ( Figure 3A and 3B) . Approximately 60% and 70% of NETtreated ciGEnCs and HUVECs, respectively, contained transcriptionally active β-catenin within their nuclei ( Figure 3C ). To explain the mesenchymal-like phenotype of NET-treated endothelial cells (Figure 2D ), the expression of an important target gene of β-catenin, Snail1, which fulfills a key role during EndMT, 29 was analyzed. Indeed, an increased expression of Snail1 was found in both NET-treated HUVECs and ciGEnCs ( Figure 3D) . Furthermore, the expression of MMP9 and the myofibroblast marker smooth muscle actin, which are in part regulated by Snail1, 30, 31 were also upregulated in both endothelial cell types after exposure to NETs ( Figure 3D ; Figure IIIC in the online-only Data Supplement). Notably, elastase inhibition with sivelestat could completely block NET-induced Snail1, MMP9, and smooth muscle actin expression ( Figure 3D ; Figure IIIC in the online-only Data 
Glomerular NETs Are Associated With Proteinuria and EndMT in Murine LN
Next, we aimed to extend our in vitro findings to the in vivo situation. Because LN is perceived as a prototype NET-driven disease, we first studied renal biopsies from MRL/lpr mice for the presence of NETs and for markers of EndMT. For this purpose, MRL/lpr mice 32 were classified into 3 groups based on the degree and duration of proteinuria: (1) no proteinuria, (2) short-lived proteinuria, and (3) long-lived proteinuria (see and Methods in the online-only Data Supplement for concise definitions). The glomerular presence of citrullinated histone Immunofluorescence imaging clearly shows that endothelial cell-cell contacts are compromised in response to NETs (right in B, white arrows). D, HUVECs acquire a mesenchymal-like phenotype (MC-like; white arrows) after 24 h of coincubation with NETs. E, NETs promote transendothelial albumin passage in HUVECs after 2 h of coincubation, which can be prevented by the addition of 100 nmol/L sivelestat, a specific inhibitor of elastase. F and G, Inhibition of NET-associated elastase prevents VE-cadherin loss on HUVECs, as confirmed by flow cytometry (F) and Western blot (G). Scale bars: white=10 µm; red=20 µm. *P<0.05, **P<0.01, ***P<0.001, compared with control, where not specified. Statistics: unpaired Student t test (C), paired Student t test (F), or 1-way ANOVA with Bonferroni correction (A and E).
H3, an NET-specific marker frequently used in mice, 33 was analyzed ( Figure 4A ). In contrast to glomeruli of healthy CBA mice, it seemed that glomeruli of MRL/lpr mice in all 3 groups contained NETs, whereby NETs were most prominently present in glomeruli of mice with long-lived proteinuria ( Figure 4B ). The presence of glomerular NETs coincided with increased cortical Snail1 and MMP9 mRNA expression in MRL/lpr mice, particularly in those with long-lived proteinuria ( Figure 4C and 4D ). Snail1 protein expression was also specifically upregulated in the glomeruli of proteinuric MRL/ lpr mice ( Figure 4E ), whereas being absent in tubular compartments ( Figure IVA in the online-only Data Supplement). Importantly, Snail1 protein expression correlated with cortical Snail1 mRNA expression and with the amount of NETpositive glomeruli in these mice ( Figure 4F and 4G) . In addition to Snail1, MMP9 protein expression was assessed in glomeruli, whereby double-stainings with CD31 confirmed the actual endothelial origin of MMP9 rather than neutrophil influx being the source of MMP9 ( Figure IVB in the onlineonly Data Supplement). Taken together, the presence of NETs is associated with the glomerular upregulation of the EndMT markers Snail1 and MMP9 in proteinuric MRL/lpr mice.
Glomerular NETs Are Associated With Proteinuria and EndMT in Human LN
We next analyzed kidney biopsies from 8 patients with active LN for NET deposits and assessed whether the presence of renal NETs correlated with the degree of proteinuria and associated with glomerular EndMT. To identify NETs in these biopsies, kidney sections were stained for DNA and elastase ( Figure 5A ). Notably, in contrast to our experience in murine LN kidneys, a reliable staining of human LN biopsies for citrullinated histone H3 could not be obtained (data not shown). Stainings with monoclonal antibodies KM-2 (against triacetylated histone H4 [K8, 12, 16] Notably, these histone modifications were previously shown to be enriched in NETs when compared with unstimulated neutrophils. 12 Taken all stainings together, the glomerular presence of NETs could be identified in 7 of the 8 renal biopsies, ranging from 18% to 75% NET-positive glomeruli. Two human control kidneys were both negative for NETs ( Figure 5A ). There was a positive correlation between the percentage of NET-positive glomeruli and the level of proteinuria ( Figure 5B ). Because the impaired DNase I-mediated degradation of NETs was recently linked to the development of LN in patients with systemic lupus erythematosus, 10 we ought to explore whether the impaired degradation of NETs by circulatory DNase I correlated to the glomerular presence of NETs. Plasma from 4 of 8 LN patients degraded NETs poorly in vitro ( Figure 5C ; Figure VI in the online-only Data Supplement). However, no statistical differences for anti-double-stranded DNA titers, anti-NET antibody titers, the level of proteinuria, or the percentage of NET-positive glomeruli was found when comparing poor degraders with good degraders of NETs ( Figure 5D ). To replicate the findings from LN mice, Snail1 protein expression was determined in renal biopsies of LN patients with severe proteinuria (>10 g/d) and with minor proteinuria (<1 g/d) . It seemed that glomeruli of patients with severe proteinuria showed high glomerular expression of Snail1, whereas those with minor proteinuria showed no evident glomerular Snail1 expression ( Figure 5E ). Notably, peritubular endothelial cells were negative for Snail1 ( Figure IVC in the online-only Data Supplement). In summary, there is a correlation between the presence of glomerular NETs and proteinuria in LN, which in turn associated with glomerular Snail1 expression. However, the NET-degrading capacity of plasma could not be correlated to the presence of NETs in the glomeruli of LN patients.
Discussion
In the present study, we demonstrate a novel role for NETs in the transition of endothelial cells toward a mesenchymal phenotype, a process known as EndMT. EndMT is the process of cellular transdifferentiation in which endothelial cells lose their endothelial-specific markers and gain a mesenchymal phenotype. 36, 37 EndMT is important during embryonic vascular development and also plays a role during vascular repair. 38 However, EndMT has also been linked to various pathological conditions, including malignant 39 and fibrotic diseases. 40 It has been suggested that during renal fibrogenesis, mesenchymal cells emerge predominantly via transdifferentiation of local endothelial 41 and epithelial cells. 42 Thus, NETs may facilitate the development of renal fibrosis in the progression of kidney disease by converting glomerular endothelial cells to a mesenchymal phenotype. Similarly, NETs may contribute to the pool of myofibroblasts that arise from lung capillary endothelial cells during the development of pulmonary fibrosis. 43 The events that lead to pulmonary fibrosis still remain poorly understood, but the induction of EndMT by NETs may emerge as a potential pathway in diseases that are characterized by a high abundance of NETs within the lung capillaries, such as sickle cell disease 5 and transfusion-related acute lung injury. 3 Elegant studies recently demonstrated that mice unable to form NETs are indeed protected from the development of fibrosis in the heart and lungs. 44 We found that the predominant protease within NETs, neutrophil elastase, is key to the induction of EndMT by NETs. Its mode of action involved the proteolysis of endothelial VE-cadherin, a known substrate of elastase, 23 and the subsequent activation of β-catenin signaling. β-catenin is a protein with a dual function that regulates the coordination of cadherinmediated cell-cell adhesions and the transcription of genes involved in the differentiation of cells toward a mesenchymal phenotype, such as α-smooth muscle actin, vimentin, MMP9, and Snail1. 45 It was reported previously that the loss of cadherinmediated cell-cell contacts can promote junctional β-catenin release and activate β-catenin signaling. 27, 28 Therefore, the elastase-mediated loss of VE-cadherin seems to be an important initial event in the induction of EndMT through β-catenin signaling. Noteworthy, NET-mediated induction of EndMT is only observed when the concentrations of NETs are high and exceed the limited phagocytic capacity of endothelial cells for NETs. We indeed show that endothelial cells are endowed with a limited capacity to internalize NETs through the endothelial RAGE, which specifically recognizes NET-associated DNA. Interestingly, in addition to its role in the internalization of NETs, RAGE activation is also a trigger for NETosis. 46 In addition to its role in the induction of EndMT, the degradation of VE-cadherin by NET-associated elastase also caused a rapid phase of increased vascular permeability, as demonstrated by transendothelial albumin passage assays. Because the integrity of intercellular junctions, mediated particularly through VE-cadherin, is a prerequisite for maintaining a restrictive endothelial barrier, 47, 48 NETs may thus play a role in the development of edema and proteinuria by increasing vascular permeability. Indeed, activated neutrophils have long been associated with vascular leakage and pulmonary edema in transfusion-related acute lung injury and sickle cell disease. 49, 50 Similarly, elastase was previously shown to promote proteinuria in vivo, 51, 52 and inhibition of elastase earlier successfully limited proteinuria in rats. 53 More recently, Knight et al 33 found that proteinuria can be reduced in vivo in MRL/ lpr mice through the systemic inhibition of NETosis with the peptidylarginine deiminase inhibitor Cl-amidine. In line with this, we found that the degree of proteinuria correlated with the percentage of NET-positive glomeruli in MRL/lpr mice and patients with LN, which was independent from the in vitro capacity of plasma to degrade NETs. The relationship between the in vitro capacity of plasma to degrade NETs and glomerular NET depositions therefore seems complex. This may be explained by the fact that the in vivo formation and deposition of NET-containing immune complexes may cause a drop in the level of antibodies that would normally prevent the degradation of in vitro generated NETs. Alternatively, our data may raise the question whether circulatory endonucleases are actually involved in the degradation of NETs present within the kidneys. Hence, >80% of the total endonuclease activity within the kidneys is attributed to locally synthesized DNase I. 54 Importantly, an acquired, selective downregulation of renal DNase I gene expression has been reported during the progression of both murine and human LN. 55 In sum, we propose a model in which excessive NETosis overloads the phagocytic capacity of endothelial cells for NETs, resulting in (1) proteolysis of VE-cadherin, (2) the loss of endothelial cell-cell contacts, (3) the development of vascular leakage, and (4) the induction of EndMT through β-catenin signaling. Future research should be aimed at functional studies in NETosis-deficient mice, or in mice treated with NETosis inhibitors, to functionally link NETosis to EndMT in vivo. Nevertheless, our data implicate that NET-associated elastase is potentially an attractive therapeutic target whose inhibition may limit vascular leakage and profibrotic processes in a plethora of NET-driven inflammatory conditions.
